COLTENE Holding AG · SIX:CLTN

COLTENE — Investora 2020

23 slides from COLTENE's conference presentation, Sep 23, 2020

  1. Slide 1: Investora 2020

    Slide 1: Investora 2020

    Investora 2020 Gerhard Mahrle, CFO Zürich - September 23, 2020

  2. Slide 2: Safe Harbor Statement

    Slide 2: Safe Harbor Statement

    Safe Harbor Statement This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our managem

  3. Slide 3: Agenda

    Slide 3: Agenda

    Agenda COLTENE – Presentation at Investora 2020  Company Portrait  COVID-19 Impact  Response to COVID-19 pandemic  Strategy and Outlook  Q&A 3

  4. Slide 4: Company Portrait

    Slide 4: Company Portrait

    Company Portrait ” COLTENE

  5. Slide 5: COLTENE at a glance

    Slide 5: COLTENE at a glance

    COLTENE at a glance Dental supplier in niche markets • COLTENE develops, manufactures and markets premium dental materials and small equipment for dental practices. • 6 legal manufacturing sites • MedTech products of class 1, 2a, 2b, 3 • 14 sales entities supported by over 300 sales reps • 3 product

  6. Slide 6: Comprehensive product portfolio for dental treatments

    Slide 6: Comprehensive product portfolio for dental treatments

    Comprehensive product portfolio for dental treatments Dentists around the world rely on COLTENE products Infection Control Dental Preservation Efficient Treatment „The infection „Sustainable preservation „Smart & efficient control specialist“ from root to crown“ utilities dentists rely on“ Instrumen

  7. Slide 7: COLTENE has a true global setup

    Slide 7: COLTENE has a true global setup

    COLTENE has a true global setup Own sales force all around the world North America Group companies 4 Production sites 2 Workforce (FTE) 620 36% Latin America CHF 98 m 45% Group companies 1 CHF 125 m Production sites 1 Workforce (FTE) 120 Europe EMEA 12% Group companies 20 7% CHF 33 m Production site

  8. Slide 8: COLTENE products are available around the world

    Slide 8: COLTENE products are available around the world

    COLTENE products are available around the world Business model Operation Germany Textile/Paper/Hygiene Sales Distributors Servicing dentists Warehouse EMEA Europe Operation Switzerland Chemical Products Sales Distributors Asia, ROW Warehouse USA Operations NAM Sales Latin America Distributors Electr

  9. Slide 9: COLTENE production and R&D locations

    Slide 9: COLTENE production and R&D locations

    COLTENE production and R&D locations Specialized state-of-the-art production facilities Altstätten Dental Preservation Dental Preservation Toronto Canada Infection Control Langenau Germany Switzerland Efficient Treatment Efficient Treatment Cuyahoga Falls/OH Infection Control Dental Preservation Rio

  10. Slide 10: Adressable market

    Slide 10: Adressable market

    Adressable market Dental consumables and small equipment Relevant market size in 2020: ~ CHF 5.8 billion Relevant market size by segment in % 22% Infection Control (39%) 42% Dental Preservation (26%) 36% Efficient Treatment (35%) (percentage of net sales of COLTENE) COLTENE is an important player in

  11. Slide 11: COVID-19 Impact

    Slide 11: COVID-19 Impact

    COVID-19 Impact Photo: Dr. Benjamin Ezeh - Manager R&D Endodontics Coltène/Whaledent AG, Altstätten, Switzerland

  12. Slide 12: Net sales by product groups

    Slide 12: Net sales by product groups

    Net sales by product groups Products in the area Infection Control are in great demand Net sales H1 2020 by product groups Net sales H1 2020 by product groups (in CHF 1’000) (shares) H1 2019 H1 2020 60'000 55'900 50'000 43'091 35% 40'890 39% 40'000 36'400 36'283 30'000 26'715 20'000 26% 10'000 0 Inf

  13. Slide 13: Net sales by product groups

    Slide 13: Net sales by product groups

    Net sales by product groups Outstanding development in Q1 was heavily impacted by the COVID-19 pandemic Sales development H1/2020 in TCHF 12'000 140'000 10'000 120'000 8'000 100'000 80'000 COVID-19 and a very 6'000 strong CHF are heavily 60'000 impacting COLTENE’s 4'000 40'000 turnover in H1/2020! 2

  14. Slide 14: EBIT development

    Slide 14: EBIT development

    EBIT development In CHF million EBIT Bridge YTD PY to ACT - in CHF mn 15.0 10.0 5.0 12.8 [WERT].1 [WERT].3 2.6 0.0 +5.9 Net Sales 3rd decline mainly -5.0 -31.5 Favorable development of OPEX [WERT].0 driven by Covid-19 impact and -10.0 of 5.9 mn driven by reduction of negative currency impacts costs

  15. Slide 15: Response to COVID-19 pandemic

    Slide 15: Response to COVID-19 pandemic

    Response to COVID-19 pandemic Photo: med. dent. Zita Baumeler Savary – Dentist Altstätten, Switzerland

  16. Slide 16: Response to COVID-19 pandemic

    Slide 16: Response to COVID-19 pandemic

    Response to COVID-19 pandemic A comprehensive set of measures  Financials Net sales CHF 103.9 mn; -19.2% in local currencies compared to H1 2019, -23.3% in reporting currency Swiss francs EBIT margin stood at 2.5% (H1 2019: 9.4%), EBIT remained positive despite sharp fall due to COVID-19 pandemic N

  17. Slide 17: Infection Control: the measures in detail

    Slide 17: Infection Control: the measures in detail

    Infection Control The measures in detail Employees Cost Reductions Product Portfolio Marketing & Sales Integration • Temporary positions • Personnel expenses were • Biosonic Wipes integrated • Marketing expenses were • Manufacturing of Kenda eliminated, but all regular 14% lower in H1, year-on- into

  18. Slide 18: Strategy and Outlook

    Slide 18: Strategy and Outlook

    Strategy and Outlook Gerhard Mahrle, CFO

  19. Slide 19: Dental industry

    Slide 19: Dental industry

    Dental industry Mega trends Globalization and e-commerce Increasing requirements in distribution regarding quality management and regulatory affairs (MDR) Negative trend in volume due to Digitalization in better oral health in Consolidation • the dental processes developed countries in manufacturing

  20. Slide 20: What can we expect in 2020?

    Slide 20: What can we expect in 2020?

    What can we expect in 2020? Impact by and recovery from COVID-19  Impact Q1 strong and positive start into the current year Q2 high impact from government’s closing of dental practices in many key countries; upside from Infection Control Q3 hope to return gradually to normality Q4 new normal is exp

  21. Slide 21: Milestones 2020 and summary

    Slide 21: Milestones 2020 and summary

    Milestones 2020 and summary COVID-19 impact mitigated Immediate reactions in Strategic focus on Infection Adjust business to new normal with protecting employees and Control and the acquisitions investments in customer relations, business as well as cost of SciCan and Micro-Mega product innovation,

  22. Slide 22: Q&A

    Slide 22: Q&A

    Infection Control A Q&A ” COLTENE

  23. Slide 23: Thank you!

    Slide 23: Thank you!

    Thank you! COLTENE Holding AG Gerhard Mahrle, CFO Feldwiesenstrasse 20 9450 Altstätten Switzerland +41 71 757 53 80 investor@coltene.com

Source: Internet Archive copy of ap.coltene.com

More decks from COLTENE Holding AG

All 34 COLTENE decks